{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T09:42:21Z","timestamp":1786268541168,"version":"build-2736575974"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00204-026-04428-6","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T09:35:28Z","timestamp":1779269728000},"page":"4041-4064","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differential induction of hepatic CYP enzymes by tobacco products and e-cigarettes: recommendation to rethink smoking status in clinical pharmacology"],"prefix":"10.1007","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0817-7932","authenticated-orcid":false,"given":"Ann-Kathrin","family":"Lenich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Litz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa-Marie","family":"Reindl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0575-184X","authenticated-orcid":false,"given":"Stephanie","family":"Ruez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"4428_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12071467","volume":"12","author":"BH Abdelmonem","year":"2024","unstructured":"Abdelmonem BH, Abdelaal NM, Anwer EKE et al (2024) Decoding the role of CYP450 enzymes in metabolism and disease: a comprehensive review. Biomedicines 12:1467. https:\/\/doi.org\/10.3390\/biomedicines12071467","journal-title":"Biomedicines"},{"key":"4428_CR2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ejpe.2015.03.011","volume":"25","author":"HI Abdel-Shafy","year":"2016","unstructured":"Abdel-Shafy HI, Mansour MSM (2016) A review on polycyclic aromatic hydrocarbons: source, environmental impact, effect on human health and remediation. Egypt J Pet 25:107\u2013123. https:\/\/doi.org\/10.1016\/j.ejpe.2015.03.011","journal-title":"Egypt J Pet"},{"key":"4428_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-18398-w","volume":"24","author":"AM Alshutairi","year":"2024","unstructured":"Alshutairi AM, Alzahrani AH, Almontshry AM (2024) The levels of polycyclic aromatic hydrocarbons in traditional cigarettes and E-cigarettes in Saudi Arabia markets: a comparative risk assessment study. BMC Public Health 24:2860. https:\/\/doi.org\/10.1186\/s12889-024-18398-w","journal-title":"BMC Public Health"},{"key":"4428_CR4","unstructured":"American Cancer Society (2021) Cancer prevention & early detection facts & figures 2021\u20132022"},{"key":"4428_CR5","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1086\/685016","volume":"6","author":"C Becker","year":"2016","unstructured":"Becker C, Frey R, Unger S et al (2016) Pharmacokinetic interaction of Riociguat with ketoconazole, clarithromycin, and midazolam. Pulm Circ 6:S49\u2013S57. https:\/\/doi.org\/10.1086\/685016","journal-title":"Pulm Circ"},{"key":"4428_CR6","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1615\/critreveukargeneexpr.v18.i3.20","volume":"18","author":"TV Beischlag","year":"2008","unstructured":"Beischlag TV, Morales JL, Hollingshead BD, Perdew GH (2008) The aryl hydrocarbon receptor complex and the control of gene expression. Crit Rev Eukaryot Gene Expr 18:207\u2013250. https:\/\/doi.org\/10.1615\/critreveukargeneexpr.v18.i3.20","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"4428_CR7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.17179\/excli2019-2005","volume":"19","author":"A Braeuning","year":"2020","unstructured":"Braeuning A, Mentz A, Schmidt FF et al (2020) RNA-protein correlation of liver toxicity markers in HepaRG cells. Excli J 19:135\u2013153. https:\/\/doi.org\/10.17179\/excli2019-2005","journal-title":"Excli J"},{"key":"4428_CR8","doi-asserted-by":"publisher","first-page":"7738","DOI":"10.1021\/acsomega.9b02836","volume":"5","author":"C-Y Chen","year":"2020","unstructured":"Chen C-Y, Papadopoulos KD (2020) Temperature and salting out effects on nicotine dissolution kinetics in saline solutions. ACS Omega 5:7738\u20137744. https:\/\/doi.org\/10.1021\/acsomega.9b02836","journal-title":"ACS Omega"},{"key":"4428_CR9","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.lungcan.2015.06.011","volume":"89","author":"M Das","year":"2015","unstructured":"Das M, Padda SK, Frymoyer A et al (2015) Dovitinib and Erlotinib in patients with metastatic non-small cell lung cancer: a drug\u2013drug interaction. Lung Cancer 89:280\u2013286. https:\/\/doi.org\/10.1016\/j.lungcan.2015.06.011","journal-title":"Lung Cancer"},{"key":"4428_CR10","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/00007691-199808000-00002","volume":"20","author":"SX Dong","year":"1998","unstructured":"Dong SX, Ping ZZ, Xiao WZ et al (1998) Effect of active and passive cigarette smoking on CYP1A2-mediated Phenacetin disposition in Chinese subjects. Ther Drug Monit 20:371\u2013375. https:\/\/doi.org\/10.1097\/00007691-199808000-00002","journal-title":"Ther Drug Monit"},{"key":"4428_CR11","doi-asserted-by":"publisher","first-page":"692.3","DOI":"10.1096\/fasebj.2018.32.1_supplement.692.3","volume":"32","author":"M Duggar","year":"2018","unstructured":"Duggar M, Swanson H, Hill\u2010Odom M (2018) Determining the effects of e\u2010cigarette vapor on oral epithelial cells in a cultured cell model. FASEB J 32:692.3-692.3. https:\/\/doi.org\/10.1096\/fasebj.2018.32.1_supplement.692.3","journal-title":"FASEB J"},{"key":"4428_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18332\/tpc\/196350","volume":"10","author":"LL Ermann","year":"2024","unstructured":"Ermann LL, Klefbom L (2024) Swedish tobacco policy: key learnings to decrease smoking and challenges that still lie ahead. Tob Prev Cess 10:1\u20133. https:\/\/doi.org\/10.18332\/tpc\/196350","journal-title":"Tob Prev Cess"},{"key":"4428_CR13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1742-7843.2005.pto_973160.x","volume":"97","author":"MS Faber","year":"2005","unstructured":"Faber MS, Jetter A, Fuhr U (2005) Assessment of CYP1A2 activity in clinical practice: why, how, and when? Basic Clin Pharmacol Toxicol 97:125\u2013134. https:\/\/doi.org\/10.1111\/j.1742-7843.2005.pto_973160.x","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"4428_CR14","unstructured":"FDA (2025) For healthcare professionals | FDA\u2019s examples of drugs that interact with CYP enzymes and transporter systems. https:\/\/www.fda.gov\/drugs\/drug-interactions-labeling\/healthcare-professionals-fdas-examples-drugs-interact-cyp-enzymes-and-transporter-systems. Accessed 5 Aug 2025"},{"key":"4428_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13020270","volume":"13","author":"LM Fuhr","year":"2021","unstructured":"Fuhr LM, Marok FZ, Hanke N et al (2021) Pharmacokinetics of the CYP3A4 and CYP2B6 inducer carbamazepine and its drug\u2013drug interaction potential: a physiologically based pharmacokinetic modeling approach. Pharmaceutics 13:270. https:\/\/doi.org\/10.3390\/pharmaceutics13020270","journal-title":"Pharmaceutics"},{"key":"4428_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/17425255.2024.2309212","volume":"20","author":"RRF Gee","year":"2024","unstructured":"Gee RRF, Huber AD, Chen T (2024) Regulation of PXR in drug metabolism: chemical and structural perspectives. Expert Opin Drug Metab Toxicol 20:9\u201323. https:\/\/doi.org\/10.1080\/17425255.2024.2309212","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"4428_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18332\/tid\/188867","volume":"22","author":"S Ghazi","year":"2024","unstructured":"Ghazi S, Song M-A, El-Hellani A (2024) A scoping review of the toxicity and health impact of IQOS. Tob Induc Dis 22:1\u201316. https:\/\/doi.org\/10.18332\/tid\/188867","journal-title":"Tob Induc Dis"},{"key":"4428_CR18","unstructured":"Gilchrist M (2025) Philip Morris international\u2019s response to \u201cunderstanding heated tobacco products: current issues and recent findings\u201d (STOP\u2014April 2025\u2014the \u201cReport\u201d)"},{"key":"4428_CR19","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3390\/ijms22010372","volume":"22","author":"L Goedtke","year":"2020","unstructured":"Goedtke L, Sprenger H, Hofmann U et al (2020) Polycyclic aromatic hydrocarbons activate the aryl hydrocarbon receptor and the constitutive androstane receptor to regulate xenobiotic metabolism in human liver cells. Int J Mol Sci 22:372. https:\/\/doi.org\/10.3390\/ijms22010372","journal-title":"Int J Mol Sci"},{"key":"4428_CR20","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/jat\/bkab076","volume":"46","author":"S Guan","year":"2021","unstructured":"Guan S, Bush L, Ji H (2021) An in vitro study of constituents released from smokeless tobacco products into human saliva. J Anal Toxicol 46:625\u2013632. https:\/\/doi.org\/10.1093\/jat\/bkab076","journal-title":"J Anal Toxicol"},{"key":"4428_CR21","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.13005\/bpj\/3162","volume":"18","author":"MNMM Hatta","year":"2025","unstructured":"Hatta MNMM, Latip NA (2025) Comprehensive review of CYP2B6 transcriptional modulators, variants, and their role in drug interactions. Biomed Pharmacol J 18:1191\u20131207. https:\/\/doi.org\/10.13005\/bpj\/3162","journal-title":"Biomed Pharmacol J"},{"key":"4428_CR22","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/cpt.1860","volume":"108","author":"DFG Hendriks","year":"2020","unstructured":"Hendriks DFG, Vorrink SU, Smutny T et al (2020) Clinically relevant cytochrome P450 3A4 induction mechanisms and drug screening in three-dimensional spheroid cultures of primary human hepatocytes. Clin Pharmacol Ther 108:844\u2013855. https:\/\/doi.org\/10.1002\/cpt.1860","journal-title":"Clin Pharmacol Ther"},{"key":"4428_CR23","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.8550","volume":"20","author":"G Hsu","year":"2018","unstructured":"Hsu G, Sun JY, Zhu S-H (2018) Evolution of electronic cigarette brands from 2013\u20132014 to 2016\u20132017: analysis of brand websites. J Med Internet Res 20:e80. https:\/\/doi.org\/10.2196\/jmir.8550","journal-title":"J Med Internet Res"},{"key":"4428_CR24","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1124\/dmd.112.047308","volume":"40","author":"Q Huang","year":"2012","unstructured":"Huang Q, Deshmukh RS, Ericksen SS et al (2012) Preferred binding orientations of Phenacetin in CYP1A1 and CYP1A2 are associated with isoform-selective metabolism. Drug Metab Dispos 40:2324\u20132331. https:\/\/doi.org\/10.1124\/dmd.112.047308","journal-title":"Drug Metab Dispos"},{"key":"4428_CR25","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1111\/j.1365-2125.2011.04023.x","volume":"72","author":"J Hukkanen","year":"2011","unstructured":"Hukkanen J, Iii PJ, Peng M et al (2011) Effect of nicotine on cytochrome P450 1A2 activity. Br J Clin Pharmacol 72:836\u2013838. https:\/\/doi.org\/10.1111\/j.1365-2125.2011.04023.x","journal-title":"Br J Clin Pharmacol"},{"key":"4428_CR26","unstructured":"ICH (1995) Structure and content of clinical study reports E3"},{"key":"4428_CR27","unstructured":"ICH (1998) Statistical principles for clinical trials E9"},{"key":"4428_CR28","unstructured":"ICH (2022) Guideline on bioanalytical method validation M10"},{"key":"4428_CR29","unstructured":"ICH (2024) Drug interaction studies M12"},{"key":"4428_CR32","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1002\/cpt.2887","volume":"113","author":"E J\u00e4rvinen","year":"2023","unstructured":"J\u00e4rvinen E, Hammer HS, P\u00f6tz O et al (2023) 3D spheroid primary human hepatocytes for prediction of cytochrome P450 and drug transporter induction. Clin Pharmacol Ther 113:1284\u20131294. https:\/\/doi.org\/10.1002\/cpt.2887","journal-title":"Clin Pharmacol Ther"},{"key":"4428_CR33","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1124\/dmd.123.001348","volume":"52","author":"K Kanamori","year":"2024","unstructured":"Kanamori K, Ahmad SM, Hamid A, Lutfy K (2024) Chronic exposure to E-cigarettes elevates CYP2A5 activity, protein expression, and cotinine-induced production of reactive oxygen species in mice. Drug Metab Dispos 52:171\u2013179. https:\/\/doi.org\/10.1124\/dmd.123.001348","journal-title":"Drug Metab Dispos"},{"key":"4428_CR34","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.118.081927","author":"JR Kenny","year":"2018","unstructured":"Kenny JR, Ramsden D, Buckley DB et al (2018) Considerations from the IQ induction working group in response to drug\u2013drug interaction guidances from regulatory agencies: focus on CYP3A4 mRNA in vitro response thresholds, variability, and clinical relevance. Drug Metab Dispos. https:\/\/doi.org\/10.1124\/dmd.118.081927","journal-title":"Drug Metab Dispos"},{"key":"4428_CR35","doi-asserted-by":"publisher","DOI":"10.35198\/01-2020-002-0007","author":"A Kulh\u00e1nek","year":"2020","unstructured":"Kulh\u00e1nek A, Baptistov\u00e1 A (2020) Chemical composition of electronic cigarette e-liquids: overview of current evidence of toxicity. Adiktologie J. https:\/\/doi.org\/10.35198\/01-2020-002-0007","journal-title":"Adiktologie J"},{"key":"4428_CR36","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3923\/pjbs.2021.790.800","volume":"24","author":"N Kuncharoen","year":"2021","unstructured":"Kuncharoen N, Chatuphonp W, Jarukamjor K (2021) Differential impacts of phenol red on benzo[a]pyrene and dexamethasone-modified cytochrome P450s in human cancer cells. Pak J Biol Sci 24:790\u2013800. https:\/\/doi.org\/10.3923\/pjbs.2021.790.800","journal-title":"Pak J Biol Sci"},{"key":"4428_CR37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s12272-021-01306-w","volume":"44","author":"Y-J Kwon","year":"2021","unstructured":"Kwon Y-J, Shin S, Chun Y-J (2021) Biological roles of cytochrome P450 1A1, 1A2, and 1B1 enzymes. Arch Pharmacal Res 44:63\u201383. https:\/\/doi.org\/10.1007\/s12272-021-01306-w","journal-title":"Arch Pharmacal Res"},{"key":"4428_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.692234","volume":"12","author":"IM Langmia","year":"2021","unstructured":"Langmia IM, Just KS, Yamoune S et al (2021) CYP2B6 functional variability in drug metabolism and exposure across populations\u2014implication for drug safety, dosing, and individualized therapy. Front Genet 12:692234. https:\/\/doi.org\/10.3389\/fgene.2021.692234","journal-title":"Front Genet"},{"key":"4428_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/bdd.1901","volume":"36","author":"U Lee","year":"2015","unstructured":"Lee U, Oh E (2015) Pharmacokinetic changes of drugs in a rat model of liver cirrhosis induced by dimethylnitrosamine, alone and in combination with diabetes mellitus induced by streptozotocin. Biopharm Drug Dispos 36:1\u201314. https:\/\/doi.org\/10.1002\/bdd.1901","journal-title":"Biopharm Drug Dispos"},{"key":"4428_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-025-04135-8","author":"A-K Lenich","year":"2025","unstructured":"Lenich A-K, Ruez S (2025a) Evaluating CYP enzyme induction by cigarette smoking: a new in vitro approach using primary human hepatocytes. Arch Toxicol. https:\/\/doi.org\/10.1007\/s00204-025-04135-8","journal-title":"Arch Toxicol"},{"key":"4428_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-025-04238-2","author":"A-K Lenich","year":"2025","unstructured":"Lenich A-K, Ruez S (2025b) Insights from a novel in vitro cigarette smoke induction model: comparison of 24 primary human hepatocyte donors of diverse demographics and multiple sources. Arch Toxicol. https:\/\/doi.org\/10.1007\/s00204-025-04238-2","journal-title":"Arch Toxicol"},{"key":"4428_CR42","doi-asserted-by":"publisher","first-page":"100230","DOI":"10.1016\/j.dmd.2025.100230","volume":"8","author":"A-K Lenich","year":"2025","unstructured":"Lenich A-K, Alsdorf S, Ruez S (2025a) Influence of 3D architecture and coculture on in vitro CYP Enzyme metabolism and induction: benchmarking human hepatic spheroids for studies in drug development. Drug Metab Dispos 8:100230. https:\/\/doi.org\/10.1016\/j.dmd.2025.100230","journal-title":"Drug Metab Dispos"},{"key":"4428_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.dmd.2025.100064","author":"A-K Lenich","year":"2025","unstructured":"Lenich A-K, Nilles J, Scherer V et al (2025b) Assessing Granisetron as a specific CYP1A1 substrate in primary human hepatocytes: a comprehensive evaluation for drug development studies. Drug Metab Dispos. https:\/\/doi.org\/10.1016\/j.dmd.2025.100064","journal-title":"Drug Metab Dispos"},{"key":"4428_CR44","doi-asserted-by":"publisher","unstructured":"Li X, Tran L, Nguyen T et al (2023) Vitamin E acetate aerosol induces hemeoxygenase-1 and cytochrome P4501A1 mRNA expression in human U937 macrophages. In: B67 lung\u2019s A stage: immune cells play, pp A3998\u2013A3998. https:\/\/doi.org\/10.1164\/ajrccm-conference.2023.207.1_meetingabstracts.a3998","DOI":"10.1164\/ajrccm-conference.2023.207.1_meetingabstracts.a3998"},{"key":"4428_CR45","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2016.03.014","volume":"165","author":"Y Liu","year":"2016","unstructured":"Liu Y, Beyer A, Aebersold R (2016) On the dependency of cellular protein levels on mRNA abundance. Cell 165:535\u2013550. https:\/\/doi.org\/10.1016\/j.cell.2016.03.014","journal-title":"Cell"},{"key":"4428_CR31","unstructured":"Mordor Intelligence (2025) Tobacco market size & share analysis-growth trends & forecasts (2025\u20132030). https:\/\/www.mordorintelligence.com\/industry-reports\/global-tobacco-market-industry. Accessed 6 Aug 2025"},{"key":"4428_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2021.743060","volume":"9","author":"J Margham","year":"2021","unstructured":"Margham J, McAdam K, Cunningham A et al (2021) The chemical complexity of e-cigarette aerosols compared with the smoke from a tobacco burning cigarette. Front Chem 9:743060. https:\/\/doi.org\/10.3389\/fchem.2021.743060","journal-title":"Front Chem"},{"key":"4428_CR47","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/1752-153x-7-151","volume":"7","author":"KG McAdam","year":"2013","unstructured":"McAdam KG, Faizi A, Kimpton H et al (2013) Polycyclic aromatic hydrocarbons in US and Swedish smokeless tobacco products. Chem Cent J 7:151. https:\/\/doi.org\/10.1186\/1752-153x-7-151","journal-title":"Chem Cent J"},{"key":"4428_CR48","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1093\/jnci\/82.16.1333","volume":"82","author":"TL McLemore","year":"1990","unstructured":"McLemore TL, Adelberg S, Liu MC et al (1990) Expression of CYP1A1 gene in patients with lung cancer: evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas. JNCI J Natl Cancer Inst 82:1333\u20131339. https:\/\/doi.org\/10.1093\/jnci\/82.16.1333","journal-title":"JNCI J Natl Cancer Inst"},{"key":"4428_CR49","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.pharmthera.2018.02.012","volume":"187","author":"M Mescher","year":"2018","unstructured":"Mescher M, Haarmann-Stemmann T (2018) Modulation of CYP1A1 metabolism: from adverse health effects to chemoprevention and therapeutic options. Pharmacol Ther 187:71\u201387. https:\/\/doi.org\/10.1016\/j.pharmthera.2018.02.012","journal-title":"Pharmacol Ther"},{"key":"4428_CR50","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.3390\/ijerph10104790","volume":"10","author":"A Minichino","year":"2013","unstructured":"Minichino A, Bersani FS, Cal\u00f2 WK et al (2013) Smoking behaviour and mental health disorders\u2014mutual influences and implications for therapy. Int J Environ Res Public Health 10:4790\u20134811. https:\/\/doi.org\/10.3390\/ijerph10104790","journal-title":"Int J Environ Res Public Health"},{"key":"4428_CR51","doi-asserted-by":"publisher","first-page":"365","DOI":"10.9740\/mhc.2021.11.365","volume":"11","author":"DJ Montville","year":"2021","unstructured":"Montville DJ, Lindsey JM, Leung JG (2021) Fluctuation between cigarette smoking and use of electronic nicotine delivery systems: impact on clozapine concentrations and clinical effect. Ment Health Clin 11:365\u2013368. https:\/\/doi.org\/10.9740\/mhc.2021.11.365","journal-title":"Ment Health Clin"},{"key":"4428_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17020159","volume":"17","author":"J Nguyen","year":"2025","unstructured":"Nguyen J, Joseph D, Chen X et al (2025) Improving the working models for drug\u2013drug interactions: impact on preclinical and clinical drug development. Pharmaceutics 17:159. https:\/\/doi.org\/10.3390\/pharmaceutics17020159","journal-title":"Pharmaceutics"},{"key":"4428_CR53","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1007\/s00204-024-03763-w","volume":"98","author":"J Nilles","year":"2024","unstructured":"Nilles J, Theile D, Weiss J et al (2024) Lack of CYP3A4 protein induction despite mRNA induction in primary hepatocytes exposed to rifabutin as a possible explanation for its low interaction risk in vivo. Arch Toxicol 98:2541\u20132556. https:\/\/doi.org\/10.1007\/s00204-024-03763-w","journal-title":"Arch Toxicol"},{"key":"4428_CR54","unstructured":"Onkar D (2024) Tobacco products: market data & analysis"},{"key":"4428_CR55","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1124\/dmd.122.001125","volume":"51","author":"KW Pedersen","year":"2023","unstructured":"Pedersen KW, Hansen J, Banner J et al (2023) Sex- and lifestyle-related factors are associated with altered hepatic CYP protein levels in people diagnosed with mental disorders. Drug Metab Dispos 51:1169\u20131176. https:\/\/doi.org\/10.1124\/dmd.122.001125","journal-title":"Drug Metab Dispos"},{"key":"4428_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-19761-w","volume":"12","author":"MI Pinto","year":"2022","unstructured":"Pinto MI, Thissen J, Hermes N et al (2022) Chemical characterisation of the vapour emitted by an e-cigarette using a ceramic wick-based technology. Sci Rep 12:16497. https:\/\/doi.org\/10.1038\/s41598-022-19761-w","journal-title":"Sci Rep"},{"key":"4428_CR57","unstructured":"Ponhar R (2021) Drug InterACTIONs with tobacco smoke"},{"key":"4428_CR58","unstructured":"Rodgman A, Perfetti T (2018) The chemical components of tobacco and tobacco smoke, 2nd edn"},{"key":"4428_CR59","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1136\/bmj.2.5968.414","volume":"2","author":"MA Russell","year":"1975","unstructured":"Russell MA, Wilson C, Patel UA et al (1975) Plasma nicotine levels after smoking cigarettes with high, medium, and low nicotine yields. Br Med J 2:414. https:\/\/doi.org\/10.1136\/bmj.2.5968.414","journal-title":"Br Med J"},{"key":"4428_CR60","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1177\/106002809502901113","volume":"29","author":"JR Schein","year":"1995","unstructured":"Schein JR (1995) Cigarette smoking and clinically significant drug interactions. Ann Pharmacother 29:1139\u20131148. https:\/\/doi.org\/10.1177\/106002809502901113","journal-title":"Ann Pharmacother"},{"key":"4428_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.crtox.2022.100067","volume":"3","author":"G Scherer","year":"2022","unstructured":"Scherer G, M\u00fctze J, Pluym N, Scherer M (2022) Assessment of nicotine delivery and uptake in users of various tobacco\/nicotine products. Curr Res Toxicol 3:100067. https:\/\/doi.org\/10.1016\/j.crtox.2022.100067","journal-title":"Curr Res Toxicol"},{"key":"4428_CR62","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/em.22433","volume":"62","author":"T Sharin","year":"2021","unstructured":"Sharin T, Gyasi H, Jones SP et al (2021) Concentration- and time-dependent induction of Cyp1a and DNA damage response by benzo(a)pyrene in LMH three-dimensional spheroids. Environ Mol Mutagen 62:319\u2013327. https:\/\/doi.org\/10.1002\/em.22433","journal-title":"Environ Mol Mutagen"},{"key":"4428_CR63","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0024-3205(93)90138-s","volume":"52","author":"JE Snawder","year":"1993","unstructured":"Snawder JE, Benson RW, Leakey JEA, Roberts DW (1993) The effect of propylene glycol on the P450-dependent metabolism of acetaminophen and other chemicals in subcellular fractions of mouse liver. Life Sci 52:183\u2013189. https:\/\/doi.org\/10.1016\/0024-3205(93)90138-s","journal-title":"Life Sci"},{"key":"4428_CR64","unstructured":"Statista (2024) Most used tobacco products in Germany as of December 2024"},{"key":"4428_CR65","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1165\/ajrcmb.19.5.3091","volume":"19","author":"Y Su","year":"1998","unstructured":"Su Y, Han W, Giraldo C et al (1998) Effect of cigarette smoke extract on nitric oxide synthase in pulmonary artery endothelial cells. Am J Respir Cell Mol Biol 19:819\u2013825. https:\/\/doi.org\/10.1165\/ajrcmb.19.5.3091","journal-title":"Am J Respir Cell Mol Biol"},{"key":"4428_CR66","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.3390\/ijerph16142468","volume":"16","author":"Y-W Sun","year":"2019","unstructured":"Sun Y-W, Kosinska W, Guttenplan JB (2019) E-cigarette aerosol condensate enhances metabolism of Benzo(a)pyrene to genotoxic products, and induces CYP1A1 and CYP1B1, likely by activation of the aryl hydrocarbon receptor. Int J Environ Res Public Heal 16:2468. https:\/\/doi.org\/10.3390\/ijerph16142468","journal-title":"Int J Environ Res Public Heal"},{"key":"4428_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-47138-z","volume":"9","author":"SG Tagliabue","year":"2019","unstructured":"Tagliabue SG, Faber SC, Motta S et al (2019) Modeling the binding of diverse ligands within the Ah receptor ligand binding domain. Sci Rep 9:10693. https:\/\/doi.org\/10.1038\/s41598-019-47138-z","journal-title":"Sci Rep"},{"key":"4428_CR68","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/add.16044","volume":"118","author":"H Tattan-Birch","year":"2023","unstructured":"Tattan-Birch H, Jackson SE, Kock L et al (2023) Rapid growth in disposable e-cigarette vaping among young adults in Great Britain from 2021 to 2022: a repeat cross-sectional survey. Addiction 118:382\u2013386. https:\/\/doi.org\/10.1111\/add.16044","journal-title":"Addiction"},{"key":"4428_CR69","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1007\/s11095-010-0170-2","volume":"27","author":"L Tompkins","year":"2010","unstructured":"Tompkins L, Lynch C, Haidar S et al (2010) Effects of commonly used excipients on the expression of CYP3A4 in colon and liver cells. Pharm Res 27:1703\u20131712. https:\/\/doi.org\/10.1007\/s11095-010-0170-2","journal-title":"Pharm Res"},{"key":"4428_CR70","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cbi.2007.05.001","volume":"169","author":"PA Tsuji","year":"2007","unstructured":"Tsuji PA, Walle T (2007) Benzo[a]pyrene-induced cytochrome P450 1A and DNA binding in cultured trout hepatocytes\u2014inhibition by plant polyphenols. Chem Biol Interact 169:25\u201331. https:\/\/doi.org\/10.1016\/j.cbi.2007.05.001","journal-title":"Chem Biol Interact"},{"key":"4428_CR30","unstructured":"Tobacco Insider (2025) Heated tobacco: markets. https:\/\/tobaccoinsider.com\/heated-tobacco-markets\/. Accessed 14 Aug 2025"},{"key":"4428_CR71","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.mpaic.2020.07.001","volume":"21","author":"R Vaja","year":"2020","unstructured":"Vaja R, Rana M (2020) Drugs and the liver. Anaesth Intensiv Care Med 21:517\u2013523. https:\/\/doi.org\/10.1016\/j.mpaic.2020.07.001","journal-title":"Anaesth Intensiv Care Med"},{"key":"4428_CR72","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.toxlet.2018.03.012","volume":"289","author":"G V\u00e1zquez-G\u00f3mez","year":"2018","unstructured":"V\u00e1zquez-G\u00f3mez G, Rocha-Zavaleta L, Rodr\u00edguez-Sosa M et al (2018) Benzo[a]pyrene activates an AhR\/Src\/ERK axis that contributes to CYP1A1 induction and stable DNA adducts formation in lung cells. Toxicol Lett 289:54\u201362. https:\/\/doi.org\/10.1016\/j.toxlet.2018.03.012","journal-title":"Toxicol Lett"},{"key":"4428_CR73","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1021\/acs.chemrestox.5b00190","volume":"28","author":"AT Vu","year":"2015","unstructured":"Vu AT, Taylor KM, Holman MR et al (2015) Polycyclic aromatic hydrocarbons in the mainstream smoke of popular U.S. cigarettes. Chem Res Toxicol 28:1616\u20131626. https:\/\/doi.org\/10.1021\/acs.chemrestox.5b00190","journal-title":"Chem Res Toxicol"},{"key":"4428_CR74","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1124\/dmd.32.6.647","volume":"32","author":"RL Walsky","year":"2004","unstructured":"Walsky RL, Obach RS (2004) Validated assays for human cytochrome P450 activities. Drug Metab Dispos 32:647\u2013660. https:\/\/doi.org\/10.1124\/dmd.32.6.647","journal-title":"Drug Metab Dispos"},{"key":"4428_CR75","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.117.078626","volume":"46","author":"F Wei\u00df","year":"2018","unstructured":"Wei\u00df F, Hammer HS, Klein K et al (2018) Direct quantification of cytochromes P450 and drug transporters - a rapid, targeted mass spectrometry-based immunoassay panel for tissues and cell culture lysates. Drug Metab Dispos 46:dmd.117.078626. https:\/\/doi.org\/10.1124\/dmd.117.078626","journal-title":"Drug Metab Dispos"},{"key":"4428_CR76","unstructured":"WHO (2021) The vicious cycle of tobacco use and mental illness\u2014a double burden on health. https:\/\/www.who.int\/europe\/news\/item\/08-11-2021-the-vicious-cycle-of-tobacco-use-and-mental-illness-a-double-burden-on-health. Accessed 5 Aug 2025"},{"key":"4428_CR77","unstructured":"WHO (2025) WHO report on the global tobacco epidemic, 2025"},{"key":"4428_CR78","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1021\/acs.chemrestox.9b00514","volume":"33","author":"BR Winters","year":"2020","unstructured":"Winters BR, Kochar TK, Clapp PW et al (2020) Impact of E-Cigarette liquid flavoring agents on activity of microsomal recombinant CYP2A6, the primary nicotine-metabolizing enzyme. Chem Res Toxicol 33:1689\u20131697. https:\/\/doi.org\/10.1021\/acs.chemrestox.9b00514","journal-title":"Chem Res Toxicol"},{"key":"4428_CR79","doi-asserted-by":"publisher","first-page":"11261","DOI":"10.1021\/acsomega.2c08258","volume":"8","author":"BR Winters","year":"2023","unstructured":"Winters BR, Clapp PW, Simmons SO et al (2023) E-Cigarette liquids and aldehyde flavoring agents inhibit CYP2A6 activity in lung epithelial cells. ACS Omega 8:11261\u201311266. https:\/\/doi.org\/10.1021\/acsomega.2c08258","journal-title":"ACS Omega"},{"key":"4428_CR80","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.bcp.2008.04.005","volume":"76","author":"K Yoshinari","year":"2008","unstructured":"Yoshinari K, Ueda R, Kusano K et al (2008) Omeprazole transactivates human CYP1A1 and CYP1A2 expression through the common regulatory region containing multiple xenobiotic-responsive elements. Biochem Pharmacol 76:139\u2013145. https:\/\/doi.org\/10.1016\/j.bcp.2008.04.005","journal-title":"Biochem Pharmacol"},{"key":"4428_CR81","doi-asserted-by":"publisher","first-page":"9423","DOI":"10.1007\/s11033-012-1807-5","volume":"39","author":"A-M Yousef","year":"2012","unstructured":"Yousef A-M, Bulatova NR, Newman W et al (2012) Allele and genotype frequencies of the polymorphic cytochrome P450 genes (CYP1A1, CYP3A4, CYP3A5, CYP2C9 and CYP2C19) in the Jordanian population. Mol Biol Rep 39:9423\u20139433. https:\/\/doi.org\/10.1007\/s11033-012-1807-5","journal-title":"Mol Biol Rep"},{"key":"4428_CR82","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","volume":"138","author":"UM Zanger","year":"2013","unstructured":"Zanger UM, Schwab M (2013) Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther 138:103\u2013141. https:\/\/doi.org\/10.1016\/j.pharmthera.2012.12.007","journal-title":"Pharmacol Ther"},{"key":"4428_CR83","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-025-03817-7","author":"S Zanni","year":"2025","unstructured":"Zanni S, Prete JD, Capogrossi A et al (2025) Influence of cigarette smoking on drugs\u2019 metabolism and effects: a systematic review. Eur J Clin Pharmacol. https:\/\/doi.org\/10.1007\/s00228-025-03817-7","journal-title":"Eur J Clin Pharmacol"},{"key":"4428_CR84","doi-asserted-by":"publisher","first-page":"425","DOI":"10.2165\/00003088-199936060-00004","volume":"36","author":"S Zevin","year":"1999","unstructured":"Zevin S, Benowitz NL (1999) Drug interactions with tobacco smoking. Clin Pharmacokinet 36:425\u2013438. https:\/\/doi.org\/10.2165\/00003088-199936060-00004","journal-title":"Clin Pharmacokinet"},{"key":"4428_CR85","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s40262-015-0337-4","volume":"55","author":"X Zhao","year":"2016","unstructured":"Zhao X, Wang Z, Wang Y et al (2016) Pharmacokinetics of the soluble guanylate cyclase stimulator Riociguat in healthy young Chinese male non-smokers and smokers: results of a randomized, double-blind, placebo-controlled study. Clin Pharmacokinet 55:615\u2013624. https:\/\/doi.org\/10.1007\/s40262-015-0337-4","journal-title":"Clin Pharmacokinet"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-026-04428-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-026-04428-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-026-04428-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T09:31:46Z","timestamp":1786267906000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-026-04428-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":85,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["4428"],"URL":"https:\/\/doi.org\/10.1007\/s00204-026-04428-6","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"17 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest. All authors are employees of Boehringer Ingelheim Pharma GmbH & Co. KG. The company had no role in the design, execution, interpretation, or writing of the study.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}